NCT07532902 A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer Status RECRUITING Phase PHASE1
NCT07526792 SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Status NOT_YET_RECRUITING Phase PHASE3
NCT07506057 Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy Status RECRUITING Phase PHASE2
NCT07492628 Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma Status RECRUITING Phase PHASE1
NCT07460245 Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07421700 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07390617 A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma Status RECRUITING Phase N/A
NCT07386847 A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer Status NOT_YET_RECRUITING Phase N/A
NCT07314723 9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer Status RECRUITING Phase PHASE2
NCT07285044 The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas Status RECRUITING Phase PHASE2
NCT07241793 Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) Status RECRUITING Phase PHASE2
NCT07234968 Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy Status RECRUITING Phase NA
NCT07217496 N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer Status WITHDRAWN Phase PHASE1
NCT07169734 A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07164950 Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients Status RECRUITING Phase NA